A novel machine learning model enhances colorectal cancer (CRC) prognosis and immunotherapy response prediction by ...

Edesa Biotech, Inc. (NASDAQ:EDSA) is planning for a Phase 2 study of its anti-CXCL10 monoclonal antibody for the treatment of moderate-to-severe non-segmental vitiligo patients. Vitiligo is a ...

The researchers used a three-parameter (N3) biomarker panel, which included chemokine ligand CXCL10, cytokeratin 18 fragment M30, and an adjusted body mass index. The test effectively ...

Edesa Biotech, Inc. announced a successful private placement led by Velan Capital, raising approximately $15 million to advance its CXCL10 antibody program through fiscal 2026. The offering ...

Chemokine (C-X-C motif) ligand (CXCL10), a key inflammatory factor, plays a significant role in various infectious diseases. In this study, we investigated how CXCL10 levels regulate the transition ...

The change from baseline in FFA biomarkers was selected as the primary endpoint based on previous work showing upregulation in the expression of the Th1 biomarkers CXCL9, CXCL10, and interferon ...

Dublin, June 10, 2024 (GLOBE NEWSWIRE) -- The "Thermo Fisher Scientific Inc (TMO) - Product Pipeline Analysis, 2024 Update" company profile has been added to ResearchAndMarkets.com's offering ...

Now, a simple, urine-based assay that detects the CXCL10 chemokine may make care more convenient and less invasive for the nearly 250,000 Americans living with a kidney transplant. Thermo Fisher ...

The new testing service can detect CXCL10 chemokine, providing valuable information faster than currently used tests. Credit: Gorodenkoff/Shutterstock.com. Thermo ...

Thermo Fisher Scientific One Lambda Laboratories, a CLIA facility in Fishers, Ind., has introduced a new CXCL10 testing service, which allows for non-invasive urine sample collection and testing, with ...

A new study suggest that using CXCL9 and CXCL10-producing dendritic cells alongside immunotherapy can be a promising strategy to overcome treatment resistance and improve clinical outcomes for ...

Among the 70 significant proteins, genetically proxied circulating levels of CXCL10 (C-X-C motif chemokine ligand 10) were associated with risk of coronary artery disease, large artery atherosclerotic ...